Business Wire

DUBAI-FUTURE-FOUNDATION

17.6.2024 11:14:26 CEST | Business Wire | Press release

Share
Dubai becomes the world metropolis for artificial intelligence

Dubai is increasingly becoming a global center for artificial intelligence. To this end, the metropolis of the day after tomorrow on the Gulf has pledged to train one million people in AI prompting over the next three years with Dubai Future Foundation overseeing the AI prompt program.. It is the first program of its kind in the world.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240613025960/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Omar Al Olama, the UAE´s Minister of State for AI, Digital Economy, and Remote Work Applications. (Photo: Business Wire)

“We want to be the most future-ready city and continue to prepare for the AI era by developing expertise and skills that support global technological change and put Dubai at the forefront of innovation,” said the Chairman of the Board of Trustees of the Dubai Future Foundation (DFF), Crown Prince Sheikh Hamdan bin Mohammed bin Rashid Al Maktoum, at the launch of the 'One Million AI Prompters' initiative in Dubai.

The United Arab Emirates, in which Dubai is the most important emirate alongside Abu Dhabi, is preparing for the post-oil era and wants to transform itself from an oil state into an AI power. By 2031, 40 percent of the gross domestic product is to be generated with artificial intelligence. To this end, the UAE is investing billions, has appointed the world's first Minister of State for AI, is attracting scientists to the Gulf, and is providing massive support for start-ups.

AI prompt engineering is critical to getting the best out of generative AI. It involves understanding the capabilities, limitations, and nuances of AI models and is predicted to be one of the most important skills in the future workplace.

‘One Million AI Prompters’, the first-of-its-kind prompt engineering initiative, that prepares expertise and competencies in AI prompt engineering, which involves crafting precise and effective instructions for AI systems to achieve desired outcomes in various tasks, ranging from generating creative content to solving complex challenges.

"We want to show people that there is a full spectrum of use cases. Whether you are technical or non-technical, you can utilize these tools,” said Omar Al Olama, the UAE´s Minister of State for AI, Digital Economy, and Remote Work Applications. He also highlighted the importance of developing practical prompt engineering skills, as these are crucial for the workforce of tomorrow and for enhancing quality of life through AI. Al Olama was appointed as the world's first AI Minister of State in the UAE in 2017.

World Championship in AI Prompt in Dubai

To launch the ‘One Million AI Prompters’ initiative, the first Global Prompt Engineering Championship was recently held in Dubai. Participants competed in categories beyond traditional coding, such as literature and art, highlighting the broad applicability of AI tools. In AI, a prompt refers to a specific request to a language model (e.g. ChatGPT or others) that can provide the user with an answer or solution.

The Global Prompt Engineering Championship received thousands of entries from around 100 countries. Thirty finalists from 13 countries qualified to come to Dubai to compete for the title of best prompt engineer in the competition's three categories. The winners were Australian Megan Fowkes in the art category Indian Ajay Cyril, 33, for coding, and Aditya Nair, 34, in literature. The Dubai Centre for Artificial Intelligence (DCAI) provided one million dirhams, approximately 273,000 US dollars, in prize money for the three winners.

Global competition around the United Arab Emirates

The UAE is increasingly being courted as a strategic partner by global tech giants. Microsoft, Google, and IBM already took part in the first championship with workshops. However, other companies and countries have also expressed interest in AI collaborations. There has been an AI university in the UAE since 2019 and the sovereign wealth fund Mubadala has set up a $100 billion AI fund.

Microsoft recently invested $1.5 billion in G42, the leading UAE-based artificial intelligence (AI) technology holding company. The US software giant recognizes the Gulf state's leading role in the development of artificial intelligence: “This strategic investment will enhance the UAE’s position as a global AI hub and provide further opportunities for partners and customers to innovate and grow”.

For more information on the Global Prompt Engineering Championship, please visit:
https://challenge.dub.ai/en/

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240613025960/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release

Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he

Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release

Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co

Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth

Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release

Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th

CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release

The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye